FDA Oversight of Clinical Trials Described as ‘Grossly Inadequate’
Article describes inadequate oversight relating to development of COVID-19 vaccines and predating the pandemic
Multidimensional Factors Shaped Physician Stress During Pandemic
Physicians' perceptions of occupational stress at individual level were shaped by stressors within and across four levels
Severe Outcomes From COVID-19 Up With Preexisting Neuropsych Conditions
Neuropsychiatric conditions and/or associated treatment linked to increased risk for severe outcomes from COVID-19, SARIs
Hospitalizations Up Among Infants Younger Than 6 Months During Omicron
No increase seen in prevalence of indicators of severe disease among these hospitalized infants
Adverse Events Mild, Rare With mAb Treatment for COVID-19 in Pregnancy
No differences seen in any obstetric-associated outcome or in composite 28-day COVID-19 outcome
SARS-CoV-2 Reinfection Ups Risks for Death, Hospitalization
Risks were increased, regardless of vaccination status, and increased according to number of reinfections
Moderna Booster Shot Prompts Strong Immune Response Against Omicron Subvariants
Moderna reports its updated booster shot is indeed triggering a strong immune response to the omicron variants BA.5 and BA.4
Bepirovirsen Studied for Treatment of Chronic Hepatitis B Infection
Dosage regimens for bepirovirsen explored in phase 2b, randomized, investigator-unblinded trial
Eradicating H. pylori Cuts Aspirin-Related Peptic Ulcer Bleeding in the Short Term
Protection against aspirin-associated peptic ulcer bleeding in older adults lost after the first 2.5 years
New Health Problems Post-COVID-19 Also Seen in Children, Teens
Common symptoms developing three or more months after COVID-19 infection differ between adults and children/adolescents
